**Dear Editor,**

Vitiligo is an acquired depigmentation disorder of unknown origin.^[@r1]^ Melanocytes are found in the heart valves and septum, the atrium, and the vessels, with possible role in abnormal signals and atrial arrhythmia.^[@r2]^ P-wave dispersion (PWD) is the difference between P-max and P-min in 12-lead electrocardiography.^[@r3]^ Assessment of possible risk is useful, especially regarding the accessibility of electrocardiography in all health care centers and the possible association between some electrocardiogram (ECG) alterations and the presence of arrhythmia, even in healthy subjects. Hence, the purpose of this study was to determine the PWD in vitiligo patients *vs.* control subjects. A case-control study was performed in a referral dermatology outpatient clinic in Shohada-e-Tajrish Hospital, affiliated with the Shahid Beheshti University of Medical Sciences, Tehran, Iran, during a one-year period (October 2016 to October 2017). A total of 94 participants were included in this study, *i.e.*, 47 patients with vitiligo and 47 healthy volunteers. The exclusion criteria were history of other diseases, smoking, and obesity. The medical assessment involved natural and Wood's light examinations consistent with the modified Vitiligo European Task Force form. Based on the Vitiligo European Task Force, a patient's palm, corresponding to 1% of body surface area, was used to calculate the total vitiligo extension. The P-max and P-min were calculated in all 12 ECG leads and the difference between them was defined as the PWD. Data analysis was performed using SPSS (v 18.0) software, utilizing the chi-squared test and Student's *t*-test for independent samples. Statistically significant p-values were those less than 0.05. In each group, 32 patients were female. The mean (standard deviation) age was 34.9 (12.1) and 32.8 (11.3) years in the case and control groups, respectively (p \> 0.05). The vitiligo type was vulgaris in 87.2% and acrofacial in 12.8%. The mean involved body area by vitiligo in case group was 30%. The results in [Table 1](#t1){ref-type="table"} demonstrate that PWD was alike across the case groups (p \> 0.05). The EF, heart rate, and blood pressures had no significant differences (p \> 0.05). Baldini *et al.* reported that vitiligo has been associated with other rare systemic disorders.^[@r4]^ However, there was no significant association in the present study. Fairfax *et al.* found an association between vitiligo, primary hypothyroidism, pernicious anemia, and idiopathic chronic heart block.^[@r5]^ In sum, it may be concluded that PWD in vitiligo patients *vs.* control subjects is not significantly differed. Hence, there is no screening requirement for cardiovascular disorders in patients with vitiligo.

###### 

P-max, P-min, and P-wave dispersion (PWD) across the groups

            P-max            P-min           PWD                
  --------- -------- ------- ------- ------- ------ --- ------- -------
  Case      100.00   12.06           44.17   4.25       55.83   11.65
  Control   100.17   10.52           45.70   3.89       54.47   9.85

Study conducted at the Department of Cardiac Aspects of Skin Diseases, Skin Research Center, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
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